Corpus Intelligence IC Memo — ED FRASER MEMORIAL HOSPITAL 2026-04-26 19:34 UTC
IC Memo — ED FRASER MEMORIAL HOSPITAL
Investment Committee Memorandum | FL | 21 beds | Grade D | EBITDA uplift $3.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ED FRASER MEMORIAL HOSPITAL

CCN 100134 | BAKER, FL | 21 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ED FRASER MEMORIAL HOSPITAL is a 21-bed community hospital in BAKER, FL with $40.7M in net patient revenue and a 17.8% operating margin. The hospital serves a payer mix of 57.8% Medicare, 0.0% Medicaid, and 42.2% commercial.

Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.8% to 25.1% (+736bps).

Net Revenue HCRIS$40.7M
Current EBITDA COMPUTED$7.2M
Operating Margin COMPUTED17.8%
Occupancy HCRIS10.3%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS57.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
25
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 17.8% places it above the state median. Among 25 size-comparable peers (10-42 beds), the median margin is -2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-42), prioritizing same-state peers. 25 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ED FRASER MEMORIAL HOSPITAL (Target)FL21$40.7M17.8%
MARINERS HOSPITALFL16$74.3M17.0%
HENDRY REGIONAL MEDICAL CENTERFL25$41.1M-20.8%
MIAMI JEWISH HEALTH SYSTEMS IFL32$36.6M-50.0%
ADVENTHEALTH WAUCHULAFL25$35.5M10.0%
NORTHWEST FLORIDA COMMUNITY HOFL25$35.2M-2.4%
PAM SPECIALTY HOSPITAL OF SARAFL40$26.3M13.7%
ST JOHNS REHABILITATION HOSPITFL26$24.8M-18.6%
SSH - THE VILLAGESFL40$21.8M3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$854K+210bp18mo
Cost to Collect4.5%2.5%$814K+200bp12mo
Denial Rate Reduction12.0%6.5%$805K+198bp12mo
A/R Days Reduction5200.0%3800.0%$495K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$854K
Cost to Collect
$814K
Denial Rate Reduction
$805K
A/R Days Reduction
$495K
Clean Claim Rate
$26K
Total EBITDA Uplift$3.0M
Current EBITDA$7.2M
+ RCM Uplift+$3.0M
Pro Forma EBITDA$10.2M
Current Margin17.8%
Pro Forma Margin25.1%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.1M$77.6M6.98x47.5%
Base (11x exit)10.0x11.0x$11.1M$89.0M8.00x51.6%
Bull Case9.0x11.0x$10.0M$102.5M10.24x59.2%
Bull (12x exit)9.0x12.0x$10.0M$114.8M11.47x62.9%
Bear Case11.0x10.0x$12.2M$59.0M4.83x37.0%
Bear (11x exit)11.0x11.0x$12.2M$68.9M5.63x41.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 57.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 10.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 25 hospitals with 10-42 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-45.3% / P50=-2.4% / P75=10.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.